Clinical Trial Update: A Study of TAK-079 in People With Generalized Myasthenia Gravis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for TAK-079 in generalized myasthenia gravis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• TAK-079

Snippet

Sponsor: Takeda | Conditions: Myasthenia Gravis | Phase 2 | Status: COMPLETED | Results posted: 2023-06-02